Halfway through 2026, OHE takes stock. We reflect on the defining moments of the year so far and look ahead to the policy shifts still to come. From US Most Favored Nation (MFN) pricing and its global ripple effects to rare disease access, the recent HEMA report publication and adopting broader value perspectives in HTA, and the new NICE threshold era. Join us for the analysis that helps you stay ahead.
Mid-year health check: policy, pricing & what’s coming
Date
17 June 2026, 2:00pm
Location
Online
